ECCI hosts launch of new innovation centre for biotechnology
06 February 2014
ECCI was selected as the venue for the launch of the new multi-million pound Industrial Biotechnology Innovation Centre (IBioIC), which will be based at Glasgow's Strathclyde University.
The new centre for biotechnology could create 1,500 jobs and boost Scotland's economy by £130m over five years, according to an independent forecast.
(Image PA: Finance Secretary John Swinney (left) during a visit to the Edinburgh Carbon Innovation Centre where he launched the Industrial Biotechnology Innovation Centre)
ECCI - "an example of how Scottish Government investment in innovation and new technologies is paying off" - John Swinney, Finance Secretary
Speaking at the launch, Finance Secretary John Swinney said how fitting it was to launch this new initiative at ECCI - "a great example of how the Scottish Government investment in innovation and new technologies is paying off. By bringing all parties that can collaborate together we believe these projects will make greater economic benefit to Scotland."
it would help place Scotland "at the forefront of a global transformational change" from an economy that was largely based on fossil fuels to a more modern, cleaner model which was more inclusive of industrial biotechnology.
Principal Timothy O Shea also thanked John Swinney on behalf of ECCI, adding that: "this unique model of wide and varied collaboration among universities, public sector and private sector organisations is already at work here at ECCI."
The new centre is being funded with £10m from the Scottish Funding Council (SFC), as well as being supported by both Scottish Enterprise and Highlands and Islands Enterprise (HIE).
A total of 13 higher education institutions in Scotland will be involved in the centre, with Strathclyde University taking a co-ordinating role.
IBioIC chairman Ian Shott said the new centre was a "collaboration of businesses and higher education institutions with the ambition to be truly distinctive, world-leading and responsive to the market and technology needs of industry".
He revealed the project's aim was to raise the estimated turnover of industrial biotechnology-related products from a current value of about £190m to between £2bn and £3bn by 2030.